Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas

Quetiapine Extended-Release Versus Immediate-Release Formulation

(2009) David C. Mamo et al.   JOURNAL OF CLINICAL PSYCHIATRY

Brain and Plasma Pharmacokinetics of Aripiprazole in Patients With Schizophrenia: An [18F]Fallypride PET Study

(2008) Gerhard Gründer et al.   AMERICAN JOURNAL OF PSYCHIATRY

No regional difference in dopamine D2 receptor occupancy by the second-generation antipsychotic drug risperidone in humans: a positron emission tomography study

(2008) Hiroshi Ito et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Steady-State Pharmacokinetic, Safety, and Tolerability Profiles of Quetiapine, Norquetiapine, and Other Quetiapine Metabolites in Pediatric and Adult Patients with Psychotic Disorders

(2008) Helen R. Winter et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Striatal and Extrastriatal D2/D3-Receptor-Binding Properties of Ziprasidone

(2008) Ingo Vernaleken et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Pharmacokinetics and time-course of D2 receptor occupancy induced by atypical antipsychotics in stabilized schizophrenic patients

(2008) AM Catafau et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Dose–Occupancy Study of Striatal and Extrastriatal Dopamine D2 Receptors by Aripiprazole in Schizophrenia with PET and [18F]Fallypride

(2008) Lawrence S Kegeles et al.   NEUROPSYCHOPHARMACOLOGY

Imaging Studies – Differential Action of Typical and Atypical Antipsychotics in a Network Perspective

(2008) I. Vernaleken et al.   PHARMACOPSYCHIATRY